type here...

CATEGORIES

Editors Choice

LATEST

1...353637...150Page 36 of 150

TRENDING

EDITORS CHOICE

Does Pharma Need Independent DNA Oversight?

Robert Turner, Founding Editor -
Our survival as a species could be placed in jeopardy if we don't begin to police treatments that place our DNA in harms way. Oversight is needed.

SCOPE Summit is Expected to be a Major Platform for News in Clinical Trial Innovation

Medika Life -
As the SCOPE Summit unfolds over the coming days, a steady stream of announcements is shaping how clinical research teams think about feasibility, enrollment,...

Does Artificial Intelligence (#AI) Chatbot Outperform Physicians in Patient Experience?

Gil Bashe, Medika Life Editor -
JAMA Article Draws Fire for Its Research Biases on ChatGPT and Chatbot - But Should We Ignore Its Conclusions Altogether?

Reevaluating Ehlers-Danlos Syndrome: How Vascular EDS Patients Are Left Behind

Gil Bashe, Medika Life Editor -
EDS Subtyping May Not Be a Harmless Convention, But a Recipe for Patient Danger

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories